INS and amyloidosis: This improvement is possibly attributed to metformin’s capacity to stimulate adult hippocampal neurogenesis, deter amyloid plaque formation, restore normal insulin signaling within neural cells, and ameliorate pathological alterations in neural lines subjected to chronic high-insulin conditions (29).